Lexicon Pharmaceuticals (LXRX) EBT Margin Growth (3y) (2013 - 2026)
Lexicon Pharmaceuticals (LXRX) EBT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -484.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 132.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -674,462.00 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8,006.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 71,157.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -5,319.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 9,980.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 31,363.00 |
| 10 | Lexicon Pharmaceuticals | 1.04 Bn | 846.13 Mn | 653,000.00 | 1.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.19 Mn |
| Mar 31, 2026 | 17.30 Mn |
| Dec 31, 2025 | 11.15 Mn |
| Sep 30, 2025 | 6.22 Mn |
| Jun 30, 2025 | 7.47 Mn |
| Dec 31, 2023 | -416,702.00 |
| Jun 30, 2023 | 26.34 Mn |
| Jun 30, 2022 | -7.20 Mn |
| Dec 31, 2020 | -268,379.00 |
| Jun 30, 2020 | -28.07 Mn |
| Mar 31, 2020 | -59,260.00 |
| Dec 31, 2019 | -48,859.00 |
| Mar 31, 2019 | -64,499.00 |
| Dec 31, 2018 | -16,541.00 |
| Sep 30, 2018 | 586,184.00 |
| Jun 30, 2018 | 726,656.00 |
| Mar 31, 2018 | 140,466.00 |
| Dec 31, 2017 | -5,931.00 |
| Sep 30, 2017 | 962,359.00 |
| Jun 30, 2017 | 364,057.00 |